Abstract:The aim of the present study was to investigate the biological role of glypican 3 (GPC3), and to identify its mechanism and clinical significance in the carcinogenesis of liver cancer. A total of 114 patients with liver cancer were involved. Their clinical data, hematoxylin and eosin-stained and Antigen Ki-67 protein (Ki-67) and GPC3 immunohisto-chemically-stained liver cancer tissue sections were analyzed to evaluate the correlation between the liver cancer proliferation, differentiation and GPC3 expression. Fluorescence microscopy, western blotting, MTT and reverse transcription quantitative polymerase chain reaction (RT-qPCR) assays were performed in HepG2 and HLE cell lines to investigate the potential mechanisms of action. Among the 114 patients with liver cancer enrolled in the present study, 12 exhibited well-differentiated liver cancer, of which 6 (50%) were positive for GPC3. A total of 30 cases exhibited poorly differentiated liver cancer; 26 (87%) of these expressed GPC3 and 11 cases (37%) demonstrated strong positive expression levels. The other 72 liver cancer cases were moderately differentiated; 75% (54/72) of these expressed GPC3 and 12.5% (9/72) exhibited strong positive expression levels. There was a significant association between the levels of GPC3 expression and liver cancer differentiation (chi(2)=16.306, P=0.008). Ki-67 staining as the criteria of the liver cancer cell proliferation index also indicated a cross correlation between liver cancer proliferation and GPC3 levels. Among the 39 liver cancer samples with a cell proliferation index <5%, only 2.6% (1/39) exhibited strong positive GPC3 staining, but of the 16 cases with a high cell proliferation index >50%, 6 exhibited strong GPC3 staining (37.5%). The difference of cell proliferation indexes between cancer cells were well, moderate and poorly differentiated, and was markedly significant (chi 2=26.334, P=0.002), and suggested that liver cancer cell proliferation was positively correlated with GPC3 expression (r=0.316, P=0.001). Consistently, in vitro analysis indicated that GPC3 promoted HepG2 and HLE cell growth, which was more apparent in HepG2 cells. The RT-qPCR results indicated that GPC3 promoted proliferation through the Hedgehog (Hh) pathway in HepG2 cells, but not in HLE cells. In the present study, it was demonstrated that patients with liver cancer with higher GPC3 levels exhibited poorer differentiation and higher proliferation levels. In vitro GPC3 may promote liver cancer cell lines proliferation through the Hh pathway.

CHANGES OF PHOSPHATIDYLCHOLINE‐SPECIFIC PHOSPHOLIPASE C IN HEPATOCARCINOGENESIS AND IN THE PROLIFERATION AND DIFFERENTIATION OF RAT LIVER CANCER CELLS

PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/-catenin signalling pathway

Correlation of calcium-independent phosphatidylcholine-specific phospholipase C with γ-GT in hepatoma cells

Activity of Two Kinds of Phosphatitylcholine-Specific Phospholipase C in Liver Cells

Correlation Between the Dynamic Changes of Lipids and Phospholipases During Induced Hepatocarcinogenesis

Therapeutic Inhibition of Phospholipase D1 Suppresses Hepatocellular Carcinoma.

CHOP Signal Transduction Pathway in Diethylnitrosamine-induced Rat Liver Cancer

Silencing of Phospholipase C gamma 2 Promotes Proliferation of Rat Hepatocytes In Vitro.

Up-regulated Expression of Phospholipase C, β1 is Associated with Tumor Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma

Phospholipase D as a key modulator of cancer progression

The in Vitro Effects of Phospholipase D1-mTOR Axis in Liver Fibrogenesis.

Effect of phospholipase D1 on proliferation of pancreatic cancer cells

Three Branches of Phospholipase C Signaling Pathway Promote Hepatocyte Growth in Rat Liver Regeneration.

Dynamic Expression of Cell Cycle Regulation Related Proteins During Carcinogenesis of Lung Squamous Cell Carcinoma in Rats

An Established Method of Diethylnitrosamine-induced Hepatocellular Carcinomas Rats Model Promoted by Microcystins-LR

Oncogenic Role of Phospholipase C‐γ1 in Progression of Hepatocellular Carcinoma

Establishment and refinement of a DEN-induced hepatocellular carcinoma model in rats

[Changes in TGF-beta1/Smads Signaling Pathway in Rats with Chemical Hepatocarcinogenesis].

Cell Expression Patterns of CD147 in N -Diethylnitrosamine/phenobarbital-induced Mouse Hepatocellular Carcinoma

PLCγ2 promotes apoptosis while inhibits proliferation in rat hepatocytes through PKCD/JNK MAPK and PKCD/p38 MAPK signalling.

Elevated GPC3 level promotes cell proliferation in liver cancer.